Peroxisome proliferator activated receptor-&gamma; in pathogenesis of experimental fatty liver disease

doi:10.3748/wjg.v10.i9.1329

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3146)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

411

HTML

2393

Figures (1-4)

174

Tables (1-4)

168

Sum=3146

May 1, 2004 (publication date) through Jul 28, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. May 1, 2004; 10(9): 1329-1332
Published online May 1, 2004. doi: 10.3748/wjg.v10.i9.1329

Full Size Figure Download Figure

Figure 4 Expression of PPARγ mRNA and GAPDH mRNA in the liver of rats with FLD. A: Expression of PPARγ mRNA in the liver of rats with FLD; B: Expression of GAPDH mRNA in the liver of rats with FLD. From left to right M: PCR marker; lane A: normal control; lane B: alcohol group; lane C: fat-rich diet group. Lane D: alcohol and fat-rich diet group

Citation: Zhao CY, Jiang LL, Li L, Deng ZJ, Liang BL, Li JM. Peroxisome proliferator activated receptor-γ in pathogenesis of experimental fatty liver disease. World J Gastroenterol 2004; 10(9): 1329-1332
URL: https://www.wjgnet.com/1007-9327/full/v10/i9/1329.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i9.1329